Ms. Jamie Lynn Schaub, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 954 Ridgebrook Rd Ste 330, Sparks, MD 21152 Phone: 443-212-5745 Fax: 443-212-5749 |
Physiotherapy Associates Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Sparks Valley Rd, Sparks, MD 21152 Phone: 410-472-1797 Fax: 410-472-1798 |
Rebecca Erin Schumer, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Loveton Cir Ste G100, Sparks, MD 21152 Phone: 410-472-2672 Fax: 410-472-2673 |
Darell Springer, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Loveton Cir Ste G100, Sparks, MD 21152 Phone: 410-472-2672 |
Medstar Health Physical Therapy At Hunt Valley Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Loveton Cir Ste G100, Sparks, MD 21152 Phone: 410-472-2672 Fax: 410-472-2673 |
News Archive
New data reveals the moving out of densely populated cities is a more impactful strategy than closing borders at decreasing the spread of the COVID-19 virus.
The Value of Clinical Practice Guidelines As Malpractice "Safe Harbors" - Overspending on health care has frequently been attributed to doctors practicing defensive medicine - ordering extra tests, for example - so that they avoid malpractice lawsuits. The authors of this brief write that while some have said clinical guidelines "should give caregivers a liability 'safe harbor,' shielding them from any malpractice claim for failing to provide services not included in the guideline."
Results for a pilot registry on the management and treatment of atrial fibrillation in Europe were presented yesterday by the European Society of Cardiology. AF is the commonest cardiac rhythm disorder and each of us have a one-in-four lifetime risk of developing it. Statistics show that oral anticoagulant use has increased, but new oral anticoagulant use is still low. Authors also concluded that compliance with treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal.
London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, has awarded the first three grants from its proof-of-concept (POC) fund. The awards, to teams at Imperial College London and University College London, are for research in the areas of immunotherapy, schizophrenia and heart disease.
› Verified 2 days ago